System | Type | Disorder | Pubmed |
allergy | asthm | | |
currently available KCNN4 blockers might therefore attenuate tissue fibrosis and remodeling in patients with diseases such as idiopathic pulmonary fibrosis and asthma through the inhibition of fibrocyte recruitment |
immunology | autoimmune | digestive | |
it may be possible to rapidly test whether KCa3.1 inhibitors are efficacious in patients with inflammatory bowel diseases such as Crohn disease and ulcerative colitis |
cardiovascular | atheroma | | |
CKCNN4 blockers represent a promising therapeutic strategy for atherosclerosis. |
miscelleaneous | urinary | chronic kidney disease | |
pharmacological inhibitors of KCNN4 channels may provide a novel and effective therapy to delay progression to kidney failure in patients with ADPKD |